![Christophe Mauriet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christophe Mauriet
Director/Board Member at Institut Pasteur Korea Research Foundation
Network origin in Christophe Mauriet first degree
Entity | Entity type | Industry | |
---|---|---|---|
Institut Pasteur Korea Research Foundation
![]() Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.
10
| Private Company | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christophe Mauriet via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Seoul National University | College/University | Corporate Officer/Principal Graduate Degree | |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
KAINOS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal | |
University of Illinois | College/University | Doctorate Degree | |
National OncoVenture | Chief Executive Officer | ||
University of Oklahoma | College/University | Doctorate Degree | |
Rarecells Diagnostics SAS
![]() Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward. | Packaged Software | Director/Board Member | |
Global Virus Network
![]() Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
ScreenCell SA
![]() ScreenCell SA Miscellaneous Commercial ServicesCommercial Services ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France. | Miscellaneous Commercial Services | Founder | |
Institut Pasteur
![]() Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | President | |
Compagnie Merieux Alliance SAS
![]() Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
European Personalised Medicine Association | Director/Board Member | ||
Fondation Ophtalmologique Adolphe de Rothschild
![]() Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Fondation Ophtalmologique Adolphe de Rothschild is a specialized hospital in Paris, FR that focuses on treating all pathologies related to the head and neck for both adults and children. The hospital has a pharmacy that ensures the supply of medicines and medical devices. The hospital also has a clinical research service that serves as a one-stop-shop for investigators and industrial or academic partners. The hospital is supported by the Edmond de Rothschild Foundations, which offer a Medical Fellowship program to support talented and promising young practitioners in their hospital-university dynamic. The CEO of the French company is Julien Gottsmann. | Hospital/Nursing Management | Director/Board Member | |
Fondation Mérieux | Investment Trusts/Mutual Funds | Director/Board Member | |
BIOMÉRIEUX | Medical Specialties | Director/Board Member | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
Hopital Necker-Enfants Malades | Corporate Officer/Principal | ||
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TRANSGENE | Biotechnology | Director/Board Member | |
South Korea Ministry of Science, ICT & Future Planning | General Government | Corporate Officer/Principal |
Statistics
International
France | 12 |
South Korea | 5 |
United States | 5 |
Switzerland | 2 |
Luxembourg | 2 |
Sectoral
Consumer Services | 5 |
Health Technology | 5 |
Commercial Services | 4 |
Miscellaneous | 4 |
Health Services | 3 |
Operational
Director/Board Member | 18 |
Corporate Officer/Principal | 5 |
President | 4 |
Doctorate Degree | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Christian Brechot | 16 |
In-Chul Kim | 4 |
Uh-Taek Oh | 3 |
Jin-Gyu Lee | 3 |
Byoung Kwon Oh | 1 |
Jin-Keon Pai | 1 |
Man-Seong Park | 1 |
Hyuk Lee | 1 |
Pierre-Marie Girard | 1 |
Gye Dong Choi | 1 |
- Stock Market
- Insiders
- Christophe Mauriet
- Company connections